主页 > 医学文档 >
【drug-news】生物技术产业: 谁当总统都行
By Christine McConville
Thursday, September 4, 2008 - Updated 1d 4h ago
The world’s largest biotechnology organization isn’t endorsing a candidate for president.
But when that next U.S. leader is elected, the Biotechnology Industry Organization’s members will call on him to significantly increase the federal Food and Drug Administration’s budget, so it can speed up the review process for cutting-edge medicines now waiting in the pipeline for approval.
“Our industry is led by some very, very brilliant scientists,” said Jim Greenwood, president and chief executive of BIO. “But it is critical that the FDA have personnel available to review and understand (their work.)”
Greenwood’s comments were made yesterday in Washington, D.C., during a media briefing on biotech-related legislation.
Joshua Boger, chairman of BIO’s board and CEO of Cambridge-based Vertex Pharmaceuticals Inc., also participated in the hour-long briefing.
Both men acknowledged that the American public wants health care to be less expensive.
But they said that, from the biotechnology industry’s point of view, there’s not a lot of difference between Democratic presidential nominee U.S. Sen. Barack Obama and Sen. John McCain, the Republican’s pick for president.
“Both said pretty good things about biotechnology, and both support embryonic stem cell research,” Greenwood said, “and both want to move from an ideological to a science-based policy, and both support more funding for the FDA.
“Both support stronger action on global warming and view it as human induced, and both support the development of cellulose ethanol.
“We are not endorsing a candidate because there’s not such a great difference between them,” he said.
Instead, biotech leaders will press the next president to allocate more money to the FDA to help speed up the drug-review process.
“The bottom line is we have to help the next administration achieve health-care reform,” Boger said.
Part of that reform is letting drug makers create and then sell drugs that reduce suffering and cure diseases, he said. “It is the most straightforward way to reduce medical costs,” he said. 本人已认领该文编译，48小时后若未提交译文，请其他战友自由认领。 Biotech group not endorsing for prez, but seeks more in FDA budget
By Christine McConville
Thursday, September 4, 2008 - Updated 1d 4h ago
克里斯汀·麦康威尔表示：生物技术产业不在乎谁当总统，只在乎为美国食品药品管理局寻求更多的财政预算
2008年9月4日，星期四---28小时前的消息
The world’s largest biotechnology organization isn’t endorsing a candidate for president.
世界最大的生物技术机构不偏向于支持哪一位候选人当总统。
But when that next U.S. leader is elected, the Biotechnology Industry Organization’s members will call on him to significantly increase the federal Food and Drug Administration’s budget, so it can speed up the review process for cutting-edge medicines now waiting in the pipeline for approval.
但时下正进行下一届美国总统选举，生物技术 产业机构的成员呼吁总统候选人重点增加其在联邦食品药品管理局的财政预算，以加速审批那些正在等候批准的打擦边球的药物 克里斯汀·麦康威尔表示：生物技术产业不在乎谁当总统，只在乎为美国食品药品管理局寻求更多的财政预算
2008年9月4日，星期四---28小时前的消息
世界最大的生物技术机构不偏向于支持哪一位候选人当总统。
但时下正进行下一届美国总统选举，生物技术 产业机构的成员呼吁总统候选人重点增加其在联邦食品药品管理局的财政预算，以加速审批那些正在等候批准的打擦边球的药物 文章翻译的很好，不过有一点不太清楚cutting-edge medicines 打擦边球的药物。
不知道什么意思，我查了一下
Cutting就是用刀来切东西的意思，edge就是一样东西的边缘。Cutting edge就是类似刀或斧头那种工具的锐利边缘，也就是刀口。作为习惯用语，它的意思就是：最先进的技术。Cutting edge这个俗语在美国人当中流传使用已经大约有四十年了，一般是用来形容科技发展领域最先进的研究和发明，因此这个习惯用语在科技界人士当中使用得最多。
我想应该是最新研发的药物的意思 谢谢 zhangtao1012450 的指正！把 cutting-edge medicines 翻译成 “最新研发的药物” 的确更贴切！
当初译 cutting-edge medicines 时觉得有点生涩，未经仔细琢磨将它直译了过来，确实欠妥。
本人水平有限，欢迎大家继续点评指正！
阅读本文的人还阅读：
作者:admin@医学,生命科学 2010-12-26 05:14
医学,生命科学网